Overview

Oropharyngeal cancer is a group of malignant tumours that develop in the middle part of the throat. These cancers most commonly originate in the mucosal lining of the oropharynx and may affect voice, swallowing and breathing depending on location and extent. Clinicians classify cases by whether they are associated with human papillomavirus (HPV) infection or not, since this distinction influences prognosis and treatment planning.

Anatomy and typical sites

The oropharynx includes several distinct areas where cancer can arise. These include the base of the tongue, the tonsils, the soft palate and the pharyngeal walls. Tumours may be small and limited to one site or larger and involve multiple structures, which affects symptoms and therapeutic options.

Causes and risk factors

Two broad aetiologic patterns are recognised. One major cause is persistent infection with high‑risk types of human papillomavirus, which is typically acquired through intimate contact and can lead to tumour development years later. The other pattern is linked to long‑term exposure to tobacco and alcohol; these substances injure mucosal cells and increase cancer risk. Additional factors that may contribute include weakened immune function and certain occupational or environmental exposures.

Signs, symptoms and diagnosis

Early symptoms are often subtle and can mimic benign conditions. Common presentations include:

  • Persistent sore throat or a sensation of something stuck in the throat
  • Pain or difficulty when swallowing (dysphagia)
  • Unexplained ear pain, hoarseness or voice changes
  • Enlarged or hard lymph nodes in the neck
  • Unintended weight loss or oral bleeding in some cases

Diagnosis begins with a clinical examination and may include endoscopic inspection, imaging (such as CT, MRI or PET), and a tissue biopsy to confirm malignancy. Tumour testing often includes assessment for HPV markers because that information affects staging and management.

Treatment, prognosis and follow‑up

Treatment depends on tumour stage, location, HPV status and patient factors. Options commonly used alone or in combination are:

  • Surgery to remove the tumour and sometimes nearby lymph nodes
  • Radiation therapy, frequently used as a primary treatment or after surgery
  • Chemotherapy, which may be combined with radiation for more advanced disease
  • Targeted therapies and immunotherapy for selected cases or recurrent disease

Overall outcomes vary; tumours linked to HPV infection often respond better to treatment than tobacco‑related cancers, but individual prognosis depends on many factors. Survivors commonly need long‑term support for swallowing, speech and dental health, and follow‑up to detect recurrence.

Prevention and notable facts

Primary prevention includes avoiding tobacco and limiting alcohol, and, where available, vaccination against HPV to reduce the risk of HPV‑related oropharyngeal cancers. Routine screening for asymptomatic disease in the general population is not established, so awareness of persistent throat symptoms and prompt clinical evaluation are important. Multidisciplinary care that addresses functional outcomes and quality of life is a key part of management.

For further authoritative information consult clinical guidelines and specialist resources: base of the tongue, tonsils, soft palate, pharyngeal walls, human papillomavirus.